Sequana Medical NV (SEQUA) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.254x

Based on the latest financial reports, Sequana Medical NV (SEQUA) has a cash flow conversion efficiency ratio of 0.254x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-9.93 Million ≈ $-11.61 Million USD) by net assets (€-39.17 Million ≈ $-45.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Sequana Medical NV for the company's overall valuation and market capitalisation.

Sequana Medical NV - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Sequana Medical NV's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sequana Medical NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sequana Medical NV ranked by their cash flow conversion efficiency. See SEQUA cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Senko Co. Ltd KQ:347000	0.022x
Carlos Casado BA:CADO	0.014x
SMCore.Inc KQ:007820	-0.082x
FreeCast, Inc. Class A Common Stock NASDAQ:CAST	0.408x
Precision Optics Corporation, Inc. Common stock NASDAQ:POCI	-0.036x
IBKS No2 SPAC KQ:204840	-0.088x
Rothwell International Co. Limited KQ:900260	0.415x
Mcleod Russel India Limited NSE:MCLEODRUSS	-0.521x

Annual Cash Flow Conversion Efficiency for Sequana Medical NV (2015–2024)

The table below shows the annual cash flow conversion efficiency of Sequana Medical NV from 2015 to 2024. View Sequana Medical NV stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-44.38 Million ≈ $-51.88 Million	€-20.26 Million ≈ $-23.68 Million	0.456x	-69.43%
2023-12-31	€-19.47 Million ≈ $-22.76 Million	€-29.06 Million ≈ $-33.98 Million	1.493x	-88.30%
2022-12-31	€-2.15 Million ≈ $-2.52 Million	€-27.48 Million ≈ $-32.13 Million	12.763x	-57.47%
2021-12-31	€-786.92K ≈ $-919.99K	€-23.62 Million ≈ $-27.61 Million	30.012x	+119.90%
2020-12-31	€112.76K ≈ $131.83K	€-17.01 Million ≈ $-19.88 Million	-150.806x	-655.51%
2019-12-31	€925.93K ≈ $1.08 Million	€-18.48 Million ≈ $-21.61 Million	-19.961x	-3891.86%
2018-12-31	€-18.76 Million ≈ $-21.93 Million	€-9.88 Million ≈ $-11.55 Million	0.526x	-72.08%
2017-12-31	€-4.61 Million ≈ $-5.39 Million	€-8.69 Million ≈ $-10.16 Million	1.885x	-1.40%
2016-12-31	€-6.67 Million ≈ $-7.80 Million	€-12.75 Million ≈ $-14.90 Million	1.912x	-95.17%
2015-12-31	€-284.66K ≈ $-332.79K	€-11.26 Million ≈ $-13.16 Million	39.554x	--

About Sequana Medical NV

BR:SEQUA Belgium Medical Devices

Market Cap

$55.84 Million

€47.76 Million EUR

Market Cap Rank

#22158 Global

#93 in Belgium

Share Price

€0.61

Change (1 day)

+0.00%

52-Week Range

€0.47 - €0.97

All Time High

€11.80